Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is frequently associated with type 2 diabetes. However, there is no specific medical therapy to treat this condition. Angiotensin‐converting enzyme 2 (ACE2) of the protective renin angiotensin system gener...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Indu G. Rajapaksha, Lakmie S. Gunarathne, Khashayar Asadi, Ross Laybutt, Sof Andrikopoulous, Ian E. Alexander, Mathew J. Watt, Peter W. Angus, Chandana B. Herath
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Health/LWW 2022-05-01
coleção:	Hepatology Communications
Acesso em linha:	https://doi.org/10.1002/hep4.1884
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!